Skip to content

Common Stock at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$292M0.0%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$3.12M+14.5%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$6K0.0%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$12K+20.0%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$18K+28.6%
Precigen logo
PrecigenPGEN
$0

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$907.23M+54.1%
Enterprise value$898.76M+53.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's common stock?
Sana Biotechnology (SANA) reported common stock of $27K in Q1 2026.
How has Sana Biotechnology's common stock changed year-over-year?
Sana Biotechnology's common stock increased by 17.4% year-over-year, from $23K to $27K.
What is the long-term trend for Sana Biotechnology's common stock?
Over 5 years (2020 to 2025), Sana Biotechnology's common stock has grown at a 68.3% compound annual growth rate (CAGR), from $2K to $27K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).